Review
Open access
Oct 2026
Randomised controlled trials of faecal microbiota transplantation in adult inpatients: a scoping review study protocol
Abstract Introduction Recently, Health Canada and the United States Food and Drug Administration approved the use of Rebyota, a regulated faecal microbiota transplantation (FMT) product for the treatment of recurrent and refractory Clostridium difficile infections. FMT is now being studied for other acute conditions in...
K. Durr, C. Hum, Taylor Kain et al.
· BMJ Open · 0 citations